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Abstract
Purpose Globally, lung cancer is the most common cancer and
the leading cause of cancer death. Problematically, there is a
wide variation in the management and survival for people with
lung cancer and there is limited understanding of the reasons for
these variations. To date, the views of health professionals
across relevant disciplines who deliver such care are largely
absent. The present study describes Australian health profes-
sionals’ views about barriers to lung cancer care to help build a
research and action agenda for improving lung cancer
outcomes.
Methods Qualitative semi-structured interviews were under-
taken with a multidisciplinary group of 31 Australian health
professionals working in lung cancer care for an average of
16 years (range 1–35 yrs.; SD = 10.2) seeing a mean of 116
patients annually.
Results Three superordinate themes were identified: illness
representations, cultural influences, and health system con-
text. Illness representations included three themes: symptoms
attributed as smoking-related but not cancer, health-related
stigma, and therapeutic nihilism. Cultural influence themes
included Indigenous health care preferences, language and
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communication, and sociodemographic factors. Health sys-
tem context included lack of regional services and distance
to treatment, poor care coordination, lack of effective screen-
ing methods, and health professional behaviours.
Conclusions Fractured and locally isolated approaches rou-
tinely confound responses to the social, cultural and health
system complexities that surround a diagnosis of lung cancer
and subsequent treatment. Improving outcomes for this disad-
vantaged patient group will require government, health agen-
cies, and the community to take an aggressive, integrated ap-
proach balancing health policy, treatment priorities, and soci-
etal values.
Keywords Lung cancer . Stigma . Nihilism . Health
professionals’ attitudes
Introduction
Globally, lung cancer is the most common cancer, contributing
one in five cancer deaths [1]. Due to poor survival, geographical
patterns of lung cancer incidence and mortality are similar. A
number of area-level and individual characteristics are associ-
ated with both treatment and survival. Internationally, where
people live, how well educated they are, and their extent of
socioeconomic disadvantage appear to consistently influence
access to treatment for lung cancer. Specifically, lung cancer
patients with lower education, low socioeconomic status, older
age, and who are male are less likely to receive surgery, radio-
therapy and chemotherapy, and indeed any lung cancer treat-
ment [2–4]. A systematic review of the world-wide literature
also found that area-level socioeconomic deprivation is associ-
ated with a lower likelihood of receiving surgery, chemotherapy
or any type of treatment for lung cancer [5]. However, further
research is needed to understand the causes of these disparities
so that strategies to improve lung cancer outcomes equitably
across communities can be developed.
Analysis of linked population-wide health data indicates
that in Australia, as distance from specialist thoracic health
services increases, people with lung cancer are less likely to
receive surgery and are more likely to die from the disease [6].
This burden is even greater in the Indigenous population who
experience poorer health than that in non- Indigenous
Australians, including higher lung cancer mortality rates [7].
Indigenous Australians are less likely to receive surgery for
their lung cancer, and the odds of receiving suboptimal treat-
ment for non-small cell lung cancers are higher for Indigenous
compared with those for non-Indigenous patients [8–10]. The
reasons for these disparities are complex. However,
Indigenous Australians are 2.5 times more likely to smoke
[11]; live in geographically remote areas where access to
health services is limited [11]; and are diagnosed at more
advanced stages of the disease in comparison with other
Australians [12, 13].
In addition to sociodemographic and cultural issues, illness
representations may be a barrier to early diagnosis of lung
cancer and adhering to treatment. Illness representations refer
to a person’s beliefs and expectations about their illness (e.g.,
the cause of the cancer, likelihood of cure), and these beliefs
influence responses to illness and health care [14]. In lung
cancer, health-related stigma is closely connected to beliefs
about lung cancer causation and prognosis. Stigma refers to
a characteristic that connects to a negative stereotype that sets
the stigmatised group apart as separate to the dominant group
[15]. This may lead to discrimination and if internalised by the
stigmatised person lead to feelings of shame or guilt and a fear
of discrimination [16]. In lung cancer, stigma is health-related
and conferred by a) the link between smoking and lung cancer
and b) social representations of lung cancer as self-inflicted
and as a disease with high mortality and a poor quality death
[17]. Research from North America has found stigma and
shame about lung cancer, social isolation and smoking-
related stigma to be associated with delay in seeking medical
help by lung cancer patients [18, 19]. Other researchers have
found that lung cancer patients who have more internalised
shame about their cancer are more likely to conceal their di-
agnosis from their social network [20] and that the negative
effects of stigma and shame on lung cancer patients distress
and quality of life were mediated by cancer threat and social
constraints [21]. Hence, stigma influences the patient experi-
ence of lung cancer and although objective studies of actual
discrimination in cancer treatment are not evident, stigma
seems likely to influence the care pathway. Finally, therapeutic
nihilism has been described as a barrier to lung cancer care
where some patients and clinicians may believe cure is unlike-
ly and that medical treatment for lung cancer is of little or no
value [22, 23].
To date, research exploring barriers to lung cancer care in
Australia is still emergent and the views of health profes-
sionals across relevant disciplines who deliver such care are
largely absent from this discourse.One Australian study found
beliefs amongst primary care physicians that non-smokers
with lung cancer were more worthy of sympathy; that delays
in treatment occur from the investigation of differential diag-
noses; and that anti-tobacco messaging highlighting lung can-
cer deaths deterred smokers from seekingmedical advice [24].
However, this research was limited by considering the views
of only ten primary care physicians in one Australian state and
the extent of previous clinical experience in lung cancer care
of participants was not described, nor were broader
sociodemographic or geographic issues explored. Hence, the
experiences of specialised health professionals across disci-
plines who deliver lung cancer care in the broader Australian
context remain unexplored. An understanding of these expe-
riences is a key step towards improving care.
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Accordingly, the aim of the present study was to ex-
plore the views of Australian health professionals about
which factors they believe influence clinical care and out-
comes for people with lung cancer. In doing so, we sought
to clarify policy and practice priorities from the view
point of health institutional stakeholders towards the set-
ting of an action agenda.
Method
Recruitment
Ethical approval was obtained from Griffith University
Human Research and Ethics Committee (HREC). Health pro-
fessionals experienced in managing lung cancer were identi-
fied through existing professional networks and were sent a
letter of invitation and information and consent form.
Networks such as the Australian and New Zealand Lung
Cancer Nurses Forum and Lung Foundation Australia1 were
selected to enable purposive sampling of health professionals
from a range of professional backgrounds involved in lung
cancer care. Not all possible professional backgrounds or
characteristics were represented, and therefore this is a non-
probability purposive sample. Of 91 health professionals
contacted, 54 did not respond, three refused to participate,
and three withdrew due to time constraints, leaving 31
(34 % response) participants. The majority of non-
responders were primary care physicians (38 %) and
medical/radiation oncologists (28 %); over 80 % of non-
responders were male.
Participants
Of the 31 participating health professionals, 52%were female
(see Table 1). Most were from Queensland (61.3 %), 12.9 %
from South Australia, 9.7 % from Victoria, 6.5 % from New
South Wales, and 3.2 % each from the Australian Capital
Territory, Western Australia, and Tasmania; 27 (87 %) were
in urban locations and the remainder (n = 4) in regional areas.
They had managed patients with lung cancer for a mean of
16 years (range 1–35 years; SD = 10.2) and saw a mean
number of 116 patients (range 1–500; SD = 122.6).
Qualitative interviews
Qualitative semi-structured interviews were undertaken.
Participants answered open-ended and broadly focussed ques-
tions about what factors they thought influenced 1) clinical
care and outcomes and 2) support for people with lung cancer.
Specific prompts about stigma and nihilism and the influence
of health policy or anti-smoking campaigns were then intro-
duced (See Appendix A). Participants were also prompted
about health professional, patient, carer, and Aboriginal and
Torres Strait Islander peoples’ perspectives to ensure an in-
depth consideration of at risk groups. The interview was semi-
guided with participants free to speak at length with minimal
interruption.
Data preparation and analyses
Interviews were digitally recorded. Of the 31 interviews con-
ducted, two were not able to be transcribed due to technical
difficulties; however, interviewer notes ensured no unique da-
ta were missed. The interviews took on average 33 min (min.
11 min; max. 57 min). Interviews were transcribed verbatim
with transcripts de-identified and checked for accuracy. Each
transcript was independently read by two qualitative data
coders. Major themes were identified through an iterative pro-
cess and examples documented separately by each coder.
Denzin and Lincoln’s [25] Interpretative Perspective frame-
work was applied to the qualitative data analysis. This frame-
work is concerned with identifying meaning and how it in-
forms subjective understanding. Analysis through the
Interpretative Perspective acknowledges that multiple per-
spectives of the human experience exist, and the aim of the
current study was to enrich our understanding of health pro-
fessionals’ views on the lung cancer patient’s experience.
Data analysis involved becoming thoroughly familiar
with the transcripts and examining similarities and con-
trasts in themes [26]. Concepts were noted in each case,
and emergent themes were identified by grouping similar
concepts. Prior theory (illness representations) served as a
resource for the interpretation of themes; however, the
interpretative framework also promotes the uncovering
of novel themes [27]. Themes that were identified later
1 At the time of the study Lung Foundation Australia was known as
Australian Lung Foundation
Table 1 Participants’ professional group (n = 31)
Professional group n %
Registered nurse 9 29.0
Cardiothoracic surgeon 3 9.7
Respiratory physician 3 9.7
General practitioner 3 9.7
Medical/radiation oncologist 5 16.1
Aboriginal and Torres Strait Islander health worker 2 6.5
Allied health* 5 16.1
Palliative care physician 1 3.2
*Allied health included physiotherapy, occupational therapy, social work,
and psychology
Support Care Cancer (2017) 25:497–504 499
in the process were coded in earlier narratives through a
continual reviewing process.
Upon completion of analysis of all transcripts, the coders met
to verify and discuss the thematic analysis. A small number of
interpretive discrepancies were discussed and resolved. Then, in-
text examples were identified across transcripts and documented
to illustrate and verify the labelling of each major theme.
Identified themes were verified by a third independent coder.
Data coders had social and behavioural science backgrounds.
Results
Three superordinate themes were identified: illness represen-
tations; cultural influences; and health system context. Illness
representations included three themes: symptoms attributed as
smoking-related but not cancer, health-related stigma, and
therapeutic nihilism. Cultural influence themes included
Indigenous health care preferences and relationship to coun-
try, language and communication, and sociodemographic fac-
tors. Health system context included distance to treatment,
lack of regional services, poor care coordination, and lack of
effective screening methods. Exemplar quotes for each super-
ordinate theme and most themes are presented below.
Illness representations
Across the illness journey from the point of symptoms to
diagnosis and treatments, three themes were described as bar-
riers to care: symptoms attributed as smoking-related but not
cancer, health-related stigma, and therapeutic nihilism.
Symptoms attributed as smoking-related but not cancer
At the pre-diagnosis stage, delays in treatment were related to
illness or somatic symptoms being interpreted by the patients
and by primary care physicians as smoking-related but not
indicative of cancer. These symptoms were also described as
being vague and non-specific and on this basis again not being
recognised or interpreted by the patient or clinicians as possi-
ble cancer. For example:
Well most of them are smokers, and most of – many of
them will have chronic symptoms and therefore they will
put down their symptoms simply to their smoking effect
rather than the possibility that he or she has a new
problem like lung cancer.
Health-related stigma
For health-related stigma, awareness of the causative link
between lung cancer and smoking created a barrier for
patients to seeking treatment and cancer help, as well as
causing patient distress. Participants expressed the views
that smokers may feel shame at causing their own cancer
and may avoid diagnosis and feel treatment is not de-
served; that health professionals assume lung cancer pa-
tients are smokers; and that non-smokers may feel stigma
more acutely because they are automatically assumed to
be at blame for their cancer. It was also expressed that
some patients keep smoking because they think the dam-
age is done. A minority view was that there was no stigma
associated with lung cancer.
I’ve had patients who have had lung cancer from a non-
smoking cause, they’ve been a non-smoker and they’ve
been diagnosed with lung cancer and I think they feel
that stigma even more acutely because they are lumped
in that category and regarded as people who have some
blame, some fault, in the illness that they have and it’s
very, I guess, invalidating and distressing to them to
have that sort of stigma.
Anti-smoking campaigns were described as contributing to
stigma in lung cancer with lung cancer patients being more
stigmatised by comparison to other cancers.
…like people who are diagnosed with lung cancer, they
have feelings that it’s their fault or feelings that people
will think that they’re using up their health resources
and they don’t somehow deserve them as much.
I have a real problem with the current – some of the
current anti-smoking things in that when they show
someone who – the parent and the kids are in the back-
ground, and I’m not going to be around - it’s almost
inducing, inciting a degree of shame on behalf of the
person with the condition.
In response to this, participants felt there was a need for
more positive messages about early detection and treatment
for lung cancer.
…another way of approaching the public health cam-
paign would be to say giving up smoking reduces your
risk of lung cancer and if you do get lung cancer it is
potentially treatable in some people.
Therapeutic nihilism
Therapeutic nihilism also emerged in the interviews, along-
side the view that treatment for lung cancer was futile and this
was seen as affecting not only attendance for treatment but
also other health behaviours such as smoking cessation.
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I think in every hospital, you can always think of at least
one or two of the clinicians that have that opinion, like
that nihilistic, what’s the point of doing anything, they’re
just going to die.
I think certainly if they are still a smoker at that point of
diagnosis for some it will be an opportunity to give up, but
for others theymay take the view, well, the damage is done,
I’ve got lung cancer so what’s the point in giving up now?
Tobacco control programs that used fear appeals to encour-
age smoking cessation were described as promoting nihilism
and stigma with resultant unintended negative effects on peo-
ple with or at risk of lung cancer.
I think patients get very scared by the television pro-
grams, the television ads, and so therefore don’t neces-
sarily seek medical attention or delay. And then patients
are quite reluctant to push themselves forward.
Cultural differences
A number of specific cultural issues were identified as barriers
to lung cancer care for Aboriginal and Torres Strait Islander
people, and these were represented by the themes Indigenous
health care preferences and relationship to country, language
and communication, and sociodemographic factors.
Indigenous health care preferences and relationship
to country
Within this theme, participants described a preference by
Aboriginal and Torres Strait Islander people for traditional med-
icine over Bwhite man’s^ medicine; a lack of knowledge about
cancer and cancer treatment; fear of hospitals; and counselling
services not being culturally accepted. For example:
(They) are very unlikely to approach white man’s medi-
cine. They like to use traditional medicine.
A lot of people don’t want to travel to that; they’ve never
been out of their community. They don’t know what
they’re going into. And hospital to them means that if I
go to hospital, I don’t come home.
Other issues raised that were representatives of this theme
were: the patient’s kinship group not being supportive of treat-
ment; fear of dying away from their country; and being away
from home/country support.
But it was like everyone in his family group just closed
ranks and they wanted to look after him their way. So,
yes, he did comply with some of the treatment, but only
when he wanted to with his mob.
Language and communication and sociodemographic
differences
Language and communication were important barriers for
not only Aboriginal and Torres Strait Islander people but
also for non-English speaking and other patients where
the use of medical jargon in particular was noted as prob-
lematic. Sociodemographic differences described that re-
late to cultural background were male gender and rurality
and that were seen as linked to stoic and avoidant illness
behaviours.
I’m thinking mainly men. For the whole reason often
men are, ‘No, I’m okay.’ The coping, they’re big boys,
they don’t need any help and a lot of people just don’t
seek help because they are trying to stick their head in
the sand.
It’s just the general rule of people who are in the rural
and remote areas tend to wait to see whether things are
getting worse before they go to the doctor, more than
they do in the urban areas.
Health services context
Health care context was described as contributing to delays,
and themes included lack of multidisciplinary and palliative
care services in rural and regional areas and resultant distance
to treatment centres; poor care coordination; and the lack of a
screening tool for early detections.
Lack of regional services and distance to treatment
Rurality impacted access to treatment and services and also
led to financial blocks in accessing health services and not
being able to take time off work for tests or treatment. For
example:
The more remote people are the harder it is for them to
access services, so therefore it becomes a bit of a self-
fulfilling prophecy that they become very negative about
the prospect of doing anything about their lung cancer
because they are so far away and they can’t access on-
cology services for chemotherapy for example.
Poor care coordination and lack of effective screening
methods
Other health care settings issues included lack of care coordi-
nation, under-staffed hospitals, and lack of effective screening
tools for early detection of lung cancer. For instance:
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All those patients often find themselves lost in a very
disjointed medical system. … they get the information,
they’re shocked, they don’t know where to go to next…
So I’d say a lack of infrastructure within the system to
follow people through is – lets the individual patients
down.
Health professional behaviours were also described as
blocking support, and this included gaps in services, lack of
appropriate referral points, poor knowledge about lung cancer,
and lack of responsiveness to patients’ and carers’ needs. For
instance:
It’s very clear that there are very little organised re-
sources available to carers of people with advanced
cancer, lung cancer or any other cancer. And so there
is a real issue there of how to deal with that.
Discussion
The present study presents a multi-faceted picture of disad-
vantage for lung cancer patients. Conceptually and practically,
the experiences of the patient, their family, and the health
professionals who care for them appear to be nested within
the health system and society with a network of influences
leading to systematic disadvantage. Broadly speaking, these
influences include geography or rurality, social deprivation,
culture, and the natural history and epidemiology of lung can-
cer (see Fig. 1). The dynamic of disadvantage is powered by
health policy and how this is expressed in the health system
and by the social sanctions that arise for people whose illness
is seen as self-inflicted (tobacco-related illness as self-harm)
and where the behaviour that leads to this illness (i.e.,
smoking) is socially sanctioned [28]. This means that serious
efforts to improving lung cancer outcomes will require a com-
plex and multi-focussed strategy across all these influences if
substantive change is to occur. In particular, addressing how
health systems are organised to respond to lung cancer, espe-
cially in rural and regional areas and conditions of socioeco-
nomic deprivation and cultural diversity, will be crucial.
As in previous research, stigma was described as a reason
why some patients may not seek care or support and why
treatments and support might not be offered to lung cancer
patients [18–20]. Nihilism was repeatedly reported as a reason
why clinicians may not offer treatment and why patients and
carers themselves may not accept or seek treatment. Hence,
despite early attention to this issue [22], it seems much has not
changed. Anti-tobacco campaigns were seen as a contributor
to lung cancer stigma by most participants, with the view
expressed that more positive media about lung cancer to in-
spire hope was needed. Tobacco control communications that
apply highly emotive and negative messages about smoking-
related illnesses in an effort to dissuade people from smoking
or encourage cessation can be expected to have an impact on
those who have these illnesses. Specifically, negative media
images about lung cancer are likely to be distressing for a
person who has a lung cancer diagnosis; however, a shift to
more positive messaging may be inconsistent with current
tobacco control messages. The balancing of policy, priorities,
and values for government, health agencies, and the commu-
nity is a key future question for discussion by health care
providers and researchers [29].
For Indigenous patients, disadvantage was overlaid
with complex language and cultural barriers that contrib-
ute to the gap between Indigenous and non-Indigenous
lung cancer outcomes [12, 13]. Consistent with previous
research, feelings of disconnect with health care services,
and fears about absence from home during treatment
with competing social, cultural, and family demands
were described [30]. From the Indigenous health workers
Fig. 1 Network of influencers on
lung cancer care
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and community members’ point of view, the main bar-
riers impacting on quality health care of Indigenous
Australians with lung cancer are communication and
follow-up processes [31]. One study reporting communi-
ty and allied health service use by Indigenous people
diagnosed with a mix of cancer types has shown that
while patients access multiple services, the most frequent
services used were Indigenous health services [32]. A
range of culturally appropriate hospital and community-
based services is needed for these patients (e.g. psycho-
logical counselling, assistance with travel, and accommo-
dation) from diagnosis and through the patient’s journey,
ideally with a specific Indigenous staff member as the
care provider [33]. This need also extends to the devel-
opment of well-targeted smoking cessation and preven-
tion interventions for this population [34].
Strengths of this study include representation of a
range of views of both male and female health profes-
sionals with extensive experience in lung cancer patient
care across a variety of geographic and health care set-
tings and disciplines. However, the nature of purposive
sampling adopted limits, at least in part, transferability of
these perspectives to all health professionals working in
cancer care.
In conclusion, a profound reflection is needed on how
our society has, and continues to, responded to the com-
munity and individual burden of lung cancer. As chronic
diseases escalate not only in Australia but globally,
health organisations have increasingly moved towards a
focus on personal responsibility for health and the self-
management of disease. This approach implies that given
enough effort, good health is possible for all. However,
assuming this fails to consider what matters most to in-
dividuals and what is relevant in the context in which
they live and in which their health status evolves.
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